Get the Stockscreener App
10.85
4.13%
0.43
After Hours:
10.64
-0.21
-1.94%
Nextcure Inc stock is traded at $10.85, with a volume of 29,122.
It is up +4.13% in the last 24 hours and down -22.39% over the past month.
NextCure Inc is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. The company's product candidates include; NC410 a fusion protein of LAIR-2, a fusion protein that, in combination with pembrolizumab, demonstrated early evidence of clinical activity in colorectal (CRC) and ovarian cancers, and LNCB74, an ADC that is directed to B7-H4, a clinically validated cancer target. The company is also seeking a partner for its other clinical programs such as NC525 and NC318 and its preclinical non-oncology programs NC605, for chronic bone diseases and NC181, for Alzheimer's disease.
See More
Previous Close:
$10.42
Open:
$10.44
24h Volume:
29,122
Relative Volume:
0.66
Market Cap:
$38.04M
Revenue:
-
Net Income/Loss:
$-58.52M
P/E Ratio:
-5.1914
EPS:
-2.09
Net Cash Flow:
$-45.03M
1W Performance:
-8.98%
1M Performance:
-22.39%
6M Performance:
+116.57%
1Y Performance:
+1,258%
1-Day Range:
$10.44
$11.49
1-Week Range:
$10.42
$12.55
52-Week Range:
$0.224
$15.74
Nextcure Inc Stock (NXTC) Company Profile
Name
Nextcure Inc
Sector
Industry
Phone
240-399-4900
Address
9000 VIRGINIA MANOR ROAD, SUITE 200, BELTSVILLE, MD
Compare NXTC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NXTC
Nextcure Inc
|
10.85 | 36.53M | 0 | -58.52M | -45.03M | -2.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.90 | 120.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.45 | 78.77B | 14.34B | 4.50B | 3.88B | 41.57 |
|
ARGX
Argen X Se Adr
|
840.50 | 52.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
338.06 | 45.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
340.38 | 38.73B | 4.98B | 69.59M | 525.67M | 0.5197 |
Nextcure Inc Stock (NXTC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-07-25 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Nov-04-22 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Mar-01-22 | Initiated | Ladenburg Thalmann | Buy |
| Mar-05-21 | Upgrade | Truist | Hold → Buy |
| Jan-15-21 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-16-20 | Upgrade | The Benchmark Company | Hold → Buy |
| Jul-13-20 | Downgrade | ROTH Capital | Buy → Neutral |
| Jul-13-20 | Downgrade | SunTrust | Buy → Hold |
| Jun-01-20 | Downgrade | BofA/Merrill | Buy → Neutral |
| Jun-01-20 | Downgrade | The Benchmark Company | Buy → Hold |
| May-26-20 | Initiated | JMP Securities | Mkt Outperform |
| Mar-24-20 | Initiated | The Benchmark Company | Buy |
| Mar-02-20 | Initiated | ROTH Capital | Buy |
| Jan-13-20 | Initiated | SunTrust | Buy |
| Dec-05-19 | Initiated | Needham | Buy |
| Nov-26-19 | Initiated | BTIG Research | Buy |
| Jul-09-19 | Initiated | BofA/Merrill | Buy |
| Jun-03-19 | Initiated | Morgan Stanley | Overweight |
| Jun-03-19 | Initiated | Piper Jaffray | Overweight |
View All
Nextcure Inc Stock (NXTC) Latest News
Fund Flows: What is LanzaTech Global Inc. Equity Warrant s revenue forecastMarket Movement Recap & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
getLinesFromResByArray error: size == 0 - mfd.ru
NextCure provides updates on ADC programs, reports cash position By Investing.com - Investing.com South Africa
NextCure Provides Business Update - citybiz
NextCure Updates ADC Pipeline Progress and Cash Runway - TipRanks
Next Cure Highlights Progress Across ADC Pipeline As Company Extends Cash Runway Into 2027 - Nasdaq
NextCure provides updates on ADC programs, reports cash position - Investing.com
NextCure provides business update - marketscreener.com
NextCure Provides Business Update - GlobeNewswire Inc.
Is Concord Medical Services Holdings Limited stock included in top ETFsJuly 2025 Final Week & Fast Entry Momentum Trade Alerts - bollywoodhelpline.com
Market Outlook: What’s the RSI of ON24 Inc. stockJuly 2025 Highlights & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Buyout Rumor: Can NextCure Inc stock deliver 10 annual returnsWeekly Risk Summary & Safe Entry Point Identification - Bộ Nội Vụ
Aug Setups: How liquid is NextCure Inc stockPortfolio Return Summary & AI Forecasted Stock Moves - baoquankhu1.vn
What margin trends mean for NextCure Inc. stock2025 Institutional Moves & Stock Timing and Entry Methods - Улправда
Will NextCure Inc. stock remain a Wall Street favorite2025 Technical Patterns & Weekly Breakout Stock Alerts - ulpravda.ru
Will Banzai International Inc. Equity Warrant stock deliver better than expected guidance - Улправда
Will NextCure Inc. stock maintain growth storyMarket Activity Report & Scalable Portfolio Growth Methods - Улправда
Will NextCure Inc. stock benefit from automation2025 Volume Leaders & AI Optimized Trade Strategies - Улправда
How analysts revise price targets for XYZY stockEarnings Beat & Free Real-Time Volume Trigger Notifications - Улправда
Will CO2 Energy Transition Corp. Equity Right stock outperform international peers2025 Price Targets & Low Drawdown Trading Strategies - ulpravda.ru
Why Intellinetics Inc. stock is trending among retail tradersLayoff News & Technical Buy Zone Confirmation - Улправда
How institutional buying supports NextCure Inc. stock2025 EndofYear Setup & Daily Profit Focused Screening - Улправда
Is NextCure Inc. stock resilient to inflationBull Run & High Yield Equity Trading Tips - Улправда
Risk Off: Why retail investors favor DRVN stock2025 AllTime Highs & Short-Term Trading Opportunity Alerts - moha.gov.vn
NextCure stock plunges to 52-week low, hits $0.69 - MSN
The Truth About NextCure Inc (NXTC): Hidden Biotech Underdog or Total Flop Stock? - AD HOC NEWS
Machinery Limited Builds Base for Possible ReboundFundamental Strength Indicators & Explosive Profit Growth - bollywoodhelpline.com
Options Data Show Bullish Bias in Foseco India LimitedValue Traps to Avoid & Explosive Profit Trading - bollywoodhelpline.com
Biocon Limited (BIOCON) vs yyyLong-Term Growth Stocks & Minimal Capital Growth Ideas - bollywoodhelpline.com
Jewellery Limited (LYPSAGEMS) Hits 52 Week HighDividend Stability Analysis & High Profit Investment Ideas - bollywoodhelpline.com
Short Interest in NextCure, Inc. (NASDAQ:NXTC) Expands By 29.6% - Defense World
Growth Review: Will NextCure Inc stock remain a Wall Street favoritePortfolio Value Summary & Fast Momentum Entry Tips - moha.gov.vn
Geopolitics Watch: Is NextCure Inc stock resilient to inflationEarnings Summary Report & Scalable Portfolio Growth Ideas - moha.gov.vn
Everest Kanto Cylinder Limited Stock Lags Behind Sector BenchmarksMarket Sentiment Indicators & Superior Trading Portfolio - Bollywood Helpline
Analyzing Monte Rosa Therapeutics (NASDAQ:GLUE) and NextCure (NASDAQ:NXTC) - Defense World
Is NextCure Inc. stock a buy on dips2025 Market WrapUp & Stock Market Timing Techniques - Улправда
NextCure Launches At-The-Market Stock Offering Program - The Globe and Mail
NextCure Enters ATM Offering Agreement - TradingView — Track All Markets
Is NextCure Inc. stock positioned well for digital economyQuarterly Trade Review & Long Hold Capital Preservation Plans - DonanımHaber
Aug Mood: Is NextCure Inc. stock a buy on dipsJuly 2025 Closing Moves & Weekly Market Pulse Updates - Улправда
Swing Trade: Is NextCure Inc. stock a buy on dips2025 Earnings Impact & Weekly Stock Breakout Alerts - Улправда
Death Cross: Can NextCure Inc. stock surprise with earnings upsideJuly 2025 Analyst Calls & Stock Portfolio Risk Management - Улправда
Can NextCure Inc. stock surprise with earnings upsideWeekly Trade Recap & Technical Pattern Based Signals - Улправда
NextCure (NASDAQ:NXTC) Upgraded to “Hold” at Wall Street Zen - Defense World
What sentiment indicators say about NextCure Inc. stockStock Surge & Risk Adjusted Buy/Sell Alerts - Newser
How analysts rate NextCure Inc. stock todayJuly 2025 Fed Impact & Fast Entry High Yield Stock Tips - Newser
What is the fair value of NextCure Inc. stock nowJuly 2025 Patterns & Fast Exit and Entry Strategy Plans - Newser
Will NextCure Inc. stock deliver long term returnsWeekly Profit Report & High Return Trade Guides - Newser
Nextcure Inc Stock (NXTC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):